• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转化酶 2 的多种功能及其与心血管疾病的相关性。

Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.

机构信息

Department of Biological Informatics and Experimental Therapeutics, Akita University Graduate School of Medicine, Akita 010-8543, Japan.

出版信息

Circ J. 2013;77(2):301-8. doi: 10.1253/circj.cj-12-1544. Epub 2013 Jan 18.

DOI:10.1253/circj.cj-12-1544
PMID:23328447
Abstract

Angiotensin-converting enzyme 2 (ACE2) is a negative regulator of the renin-angiotensin system, and functions as the key SARS coronavirus receptor and stabilizer of neutral amino acid transporters. ACE2 catalyzes the conversion of angiotensin II to angiotensin 1-7, thereby counterbalancing ACE activity. Accumulating evidence indicates that the enzymatic activity of ACE2 has a protective role in cardiovascular diseases. Loss of ACE2 can be detrimental, as it leads to functional deterioration of the heart and progression of cardiac, renal, and vascular pathologies. Recombinant soluble human ACE2 protein has been demonstrated to exhibit beneficial effects in various animal models, including cardiovascular diseases. ACE2 is a multifunctional enzyme and thus potentially acts on other vasoactive peptides, such as Apelin, a vital regulator of blood pressure and myocardium contractility. In addition, ACE2 is structurally a chimeric protein that has emerged from the duplication of 2 genes: homology with ACE at the carboxypeptidase domain and homology with Collectrin in the transmembrane C-terminal domain. ACE2 has been implicated in the pathology of Hartnup's disease, a disorder of amino acid homeostasis, and, via its function in amino acid transport, it has been recently revealed that ACE2 controls intestinal inflammation and diarrhea, thus regulating the gut microbiome. This review summarizes and discusses the structure and multiple functions of ACE2 and the relevance of this key enzyme in disease pathogenesis.

摘要

血管紧张素转换酶 2(ACE2)是肾素-血管紧张素系统的负调节剂,作为关键的 SARS 冠状病毒受体和中性氨基酸转运体稳定剂发挥作用。ACE2 催化血管紧张素 II 转化为血管紧张素 1-7,从而抵消 ACE 的活性。越来越多的证据表明,ACE2 的酶活性在心血管疾病中具有保护作用。ACE2 的缺失可能是有害的,因为它会导致心脏功能恶化,并促进心脏、肾脏和血管病变的进展。重组可溶性人 ACE2 蛋白已被证明在包括心血管疾病在内的各种动物模型中具有有益作用。ACE2 是一种多功能酶,因此可能作用于其他血管活性肽,如 Apelin,它是血压和心肌收缩力的重要调节剂。此外,ACE2 是一种嵌合蛋白,它是由 2 个基因的复制而产生的:羧肽酶结构域与 ACE 的同源性和跨膜 C 端结构域与 Collectrin 的同源性。ACE2 与 Hartnup 病的病理学有关,Hartnup 病是一种氨基酸稳态紊乱,通过其在氨基酸转运中的功能,最近发现 ACE2 控制肠道炎症和腹泻,从而调节肠道微生物组。这篇综述总结和讨论了 ACE2 的结构和多种功能,以及这种关键酶在疾病发病机制中的相关性。

相似文献

1
Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.血管紧张素转化酶 2 的多种功能及其与心血管疾病的相关性。
Circ J. 2013;77(2):301-8. doi: 10.1253/circj.cj-12-1544. Epub 2013 Jan 18.
2
Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.血管紧张素转化酶 2(ACE2)在疾病发病机制中的作用。
Circ J. 2010 Mar;74(3):405-10. doi: 10.1253/circj.cj-10-0045. Epub 2010 Feb 4.
3
The role of ACE2 in cardiovascular physiology.血管紧张素转换酶2(ACE2)在心血管生理学中的作用。
Trends Cardiovasc Med. 2003 Apr;13(3):93-101. doi: 10.1016/s1050-1738(02)00233-5.
4
ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.血管紧张素转换酶2及其同源物Collectrin在血压稳态和血管损伤中对一氧化氮和氧化应激的调节作用
Antioxid Redox Signal. 2017 Apr 20;26(12):645-659. doi: 10.1089/ars.2016.6950. Epub 2017 Jan 12.
5
Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.ACE2 的三部曲:肾素-血管紧张素系统中的一种肽酶、SARS 受体和氨基酸转运体的伴侣。
Pharmacol Ther. 2010 Oct;128(1):119-28. doi: 10.1016/j.pharmthera.2010.06.003. Epub 2010 Jul 3.
6
Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system.血管紧张素转换酶2与肾素-血管紧张素系统的新见解
Biochem Pharmacol. 2008 Feb 15;75(4):781-6. doi: 10.1016/j.bcp.2007.08.012. Epub 2007 Aug 17.
7
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.糖尿病与 ACE2 在实验性糖尿病心血管疾病发病机制中的相互作用。
Clin Sci (Lond). 2012 Oct;123(8):519-29. doi: 10.1042/CS20110668.
8
The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.组织肾素-血管紧张素系统的两面性:对心血管疾病的影响
Curr Pharm Des. 2007;13(12):1231-45. doi: 10.2174/138161207780618911.
9
Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease.血管紧张素转换酶 2 是心血管和肾脏疾病中肾素-血管紧张素系统的关键调节因子。
Curr Opin Nephrol Hypertens. 2011 Jan;20(1):62-8. doi: 10.1097/MNH.0b013e328341164a.
10
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.血管紧张素转换酶2与血管活性肽:心血管/肾脏重塑及高血压中的新角色
Ther Adv Cardiovasc Dis. 2015 Aug;9(4):217-37. doi: 10.1177/1753944715597623. Epub 2015 Aug 13.

引用本文的文献

1
Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其疫苗与肾素-血管紧张素-醛固酮系统的相互作用、临床结局以及血管紧张素(1-7)作为一种生理性治疗建议:假说与理论文章
Front Med (Lausanne). 2025 Jul 10;12:1612442. doi: 10.3389/fmed.2025.1612442. eCollection 2025.
2
The Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm.血管平滑肌细胞在腹主动脉瘤中的病理生理作用
Cells. 2025 Jul 2;14(13):1009. doi: 10.3390/cells14131009.
3
Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.
N-连接糖基化位点在人血管紧张素转换酶2(ACE2)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和人冠状病毒NL63(hCoV-NL63)感染中的作用
J Virol. 2025 May 20;99(5):e0220224. doi: 10.1128/jvi.02202-24. Epub 2025 Mar 28.
4
Black Chokeberry () Juice Supplementation Affects Age-Related Myocardial Remodeling in Rats.黑果腺肋花楸汁补充剂对大鼠年龄相关的心肌重塑有影响。
Life (Basel). 2024 Dec 28;15(1):23. doi: 10.3390/life15010023.
5
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches.新型冠状病毒病(COVID-19)信使核糖核酸-脂质纳米颗粒(mRNA-LNP)疫苗接种后的细胞因子风暴和过敏反应:机制与治疗方法
Diseases. 2024 Oct 1;12(10):231. doi: 10.3390/diseases12100231.
6
Aortic aneurysm: pathophysiology and therapeutic options.主动脉瘤:病理生理学与治疗选择
MedComm (2020). 2024 Sep 7;5(9):e703. doi: 10.1002/mco2.703. eCollection 2024 Sep.
7
Renin-angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?肾素-血管紧张素系统抑制剂对多种衰老调控途径有积极影响:它们可用于预防人类衰老吗?
Physiol Rep. 2024 Jun;12(12):e16094. doi: 10.14814/phy2.16094.
8
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
9
ACE2 and TMPRSS2 expression in patients before, during, and after SARS-CoV-2 infection.ACE2 和 TMPRSS2 在 SARS-CoV-2 感染前后患者中的表达。
Front Cell Infect Microbiol. 2024 Mar 28;14:1355809. doi: 10.3389/fcimb.2024.1355809. eCollection 2024.
10
Absence of a causal link between COVID-19 and deep vein thrombosis: Insights from a bi-directional Mendelian randomisation study.没有 COVID-19 与深静脉血栓形成之间因果关系的证据:来自双向孟德尔随机研究的见解。
J Glob Health. 2024 Jan 12;14:05001. doi: 10.7189/jogh.14.05001.